Vanda Pharmaceuticals Sees Unusually Large Options Volume (VNDA)
Shares of Vanda Pharmaceuticals (NASDAQ:VNDA) was the target of some unusual options trading activity on Friday. Stock investors bought 10,038 call options on the stock, AnalystRatingsNetwork reports. This represents an increase of approximately 388% compared to the typical volume of 2,056 call options.
Separately, analysts at Jefferies Group raised their price target on shares of Vanda Pharmaceuticals from $11.00 to $13.00 in a research note to investors on Tuesday, July 30th. They now have a “buy” rating on the stock.
Vanda Pharmaceuticals (NASDAQ:VNDA) traded down 3.62% on Friday, hitting $9.715. 639,979 shares of the company’s stock traded hands. Vanda Pharmaceuticals has a 1-year low of $2.92 and a 1-year high of $13.47. The stock’s 50-day moving average is $11.5 and its 200-day moving average is $8.67. The company’s market cap is $276.7 million.
Vanda Pharmaceuticals (NASDAQ:VNDA) last released its earnings data on Wednesday, July 31st. The company reported ($0.26) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.22) by $0.04. The company had revenue of $8.30 million for the quarter, compared to the consensus estimate of $8.43 million. During the same quarter in the previous year, the company posted ($0.28) earnings per share. The company’s revenue for the quarter was down 1.0% on a year-over-year basis. Analysts expect that Vanda Pharmaceuticals will post $-0.81 EPS for the current fiscal year.
Vanda Pharmaceuticals Inc (NASDAQ:VNDA) is a biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.